FMX101

DRUG3 trials

Sponsors

Vyne Therapeutics Inc., Cutia Therapeutics (Shanghai) Co., Ltd

Conditions

Acne VulgarisHealthy

Phase 1

Dermal Phototoxicity Study

CompletedNCT04070742

Vyne Therapeutics Inc.Healthy

Start: 2016-08-17End: 2016-10-01Updated: 2019-09-11

Phase 3

A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

CompletedNCT03271021

Vyne Therapeutics Inc.Acne Vulgaris

Start: 2017-07-17End: 2018-09-04Updated: 2022-01-18

To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris

CompletedNCT04960930

Cutia Therapeutics (Shanghai) Co., LtdAcne Vulgaris

Start: 2021-09-17End: 2022-10-14Updated: 2023-09-28